The short answer
A celiac antibody test needs context
tTG-IgA is a blood test for IgA antibodies against tissue transglutaminase. It is the preferred initial celiac antibody test for most patients. The result needs context, especially total IgA and gluten exposure, and should not be used alone to diagnose or exclude celiac disease.See reference 1,See reference 2
What tTG-IgA detects
The test looks for antibodies directed at a particular protein target. It does not measure gluten in the blood, the amount of intestinal damage or all IgA antibodies. “Total IgA” and “tTG-IgA” may appear beside one another on a report because they answer different questions.See reference 1,See reference 2
Celiac disease is an immune-mediated condition triggered by gluten in susceptible people. It can involve digestive symptoms and problems outside the gut. Symptoms alone do not establish the diagnosis, and a blood antibody result is one part of the assessment.See reference 4
Why total IgA matters
If total IgA is deficient, an IgA-based test can miss celiac disease. Clinicians may use IgG-based tests in this situation. This does not mean that tTG-IgG is automatically a better test for everyone: an isolated positive tTG-IgG is less useful when the person is not IgA deficient.See reference 1
A normal total IgA is not a negative celiac test. It helps establish whether an IgA-based antibody test can be used in the usual way. The antibody result, symptoms and other clinical information still need interpretation.See reference 1
Gluten exposure affects diagnostic testing
Gluten avoidance before testing can lower the antibodies being measured and can affect intestinal biopsy findings. NIDDK advises against beginning a gluten-free diet before the diagnostic work-up. A negative result after gluten restriction may therefore be difficult to interpret.See reference 2,See reference 3
If gluten has already been reduced or avoided, tell the ordering clinician before testing. A testing plan may need adjustment. This guide does not give a gluten challenge amount or duration, and should not be used to decide whether to resume gluten on your own.See reference 3
What the main result patterns mean
- Report pattern
- Positive tTG-IgA
- What it suggests
- Celiac disease becomes more likely.
- What remains unresolved
- Confirmation depends on the full clinical pathway, often including small-intestinal biopsies.See reference 2,See reference 3
- Report pattern
- Negative tTG-IgA with sufficient total IgA
- What it suggests
- Celiac disease becomes less likely.
- What remains unresolved
- Gluten exposure, test performance and continuing clinical suspicion still matter.See reference 1,See reference 2
- Report pattern
- Negative tTG-IgA with deficient total IgA
- What it suggests
- The IgA result may be unreliable for screening.
- What remains unresolved
- The clinician selects the appropriate IgG-based or other investigation.See reference 1
- Report pattern
- Testing after gluten restriction
- What it suggests
- Antibodies can decline.
- What remains unresolved
- The result may not answer the original diagnostic question.See reference 2,See reference 3
The laboratory’s antibody units matter
Mayo’s tTG-IgA assay uses U/mL and its own negative, weak-positive and positive categories. Those are assay-specific antibody units, not a mass concentration like the g/L used for total IgA. A cutoff from that assay should not be imported into a different laboratory’s report.See reference 2
Keep the numerical value, unit, laboratory interpretation, method if available and date together. If a report expresses a result relative to an upper limit, keep that limit too. A bare number copied without its assay context is incomplete information.
There is no conversion in this guide between tTG-IgA antibody units and total IgA concentration. They measure different quantities. A larger number on one test cannot be compared numerically with the result of the other.See reference 1,See reference 2
Why a blood result is not the whole diagnosis
Doctors commonly use blood tests together with biopsies of the small intestine. Special diagnostic pathways exist in selected circumstances, so it would also be misleading to say every patient always needs a biopsy. The pathway is a clinical decision, not a rule readers can apply from this page.See reference 2,See reference 3
A negative test does not end the investigation when clinical suspicion remains. Test performance can be lower in mild intestinal disease and in very young children. Those limits are reasons for clinician-led follow-up, not for choosing a diagnosis from a single result.See reference 1,See reference 2
Details worth bringing to the appointment
- The complete tTG-IgA report, including its unit and laboratory interpretation.
- The total IgA result, if one was measured.
- Whether gluten intake changed before the test, and approximately when.
- The reason for testing, previous results and any prior celiac diagnosis.
- A question about the next diagnostic step, rather than a self-selected antibody cutoff.
Common questions
Can a positive tTG-IgA diagnose celiac disease by itself?
It increases the likelihood, but the result should be assessed within the full diagnostic pathway. Confirmation and any specialist pathway depend on the person’s circumstances.See reference 2,See reference 3
Does a negative result exclude celiac disease?
Not in every circumstance. Low total IgA, gluten restriction and limited test sensitivity can affect the result, and further investigation may be appropriate if clinical suspicion remains.See reference 1,See reference 2
Is tTG-IgA a food allergy test?
It is used in celiac assessment. Celiac disease and wheat allergy are different conditions; this antibody test does not establish the cause of every symptom after eating wheat.See reference 2,See reference 4
Can a falling result prove the intestine has healed?
Antibody levels may fall after a gluten-free diet is started in diagnosed celiac disease, but the blood test is not a direct measurement of the intestinal lining. Follow-up should be interpreted by the treating team.See reference 2
References
- 1. Celiac Disease Tests
National Institute of Diabetes and Digestive and Kidney DiseasesOfficial guidance
- 2. Tissue Transglutaminase Antibody, IgA, Serum: Clinical and Interpretive Information
Mayo Clinic LaboratoriesOfficial guidance
- 3. Diagnosis of Celiac Disease
National Institute of Diabetes and Digestive and Kidney DiseasesOfficial guidance
- 4. Definition & Facts for Celiac Disease
National Institute of Diabetes and Digestive and Kidney DiseasesOfficial guidance
Editorial transparency
- Published by
- LongevityMate Editorial
- Published
- Updated
Medical disclaimer
General education only. This guide does not diagnose a condition, interpret your personal result, choose a treatment or recommend a supplement dose. Discuss testing, symptoms, medicines and supplements with a qualified health professional.
